Prevalence of age-related maculopathy (ARM) and age-related macular degeneration (AMD) by gender and age*
| Without ARM/AMD | ARM | AMD | |||
| Grade 0 (n=1779) | Grade 1 (n=165) | Grade 2 (n=44) | Grade 3 (n=8) | Grade 4 (n=71) | |
| Overall (n=2132) | 86.3 (84.5 to 87.9) | 7.9 (6.5 to 9.3) | 2.0 (1.3 to 2.7) | 0.4 (0.1 to 0.7) | 3.4 (2.5 to 4.3) |
| Gender | |||||
| Men (n=840) | 87.6 (84.9 to 90.3) | 7.4 (5.3 to 9.5) | 1.1 (1.3 to 3.9) | 0.3 (0.0 to 0.7) | 3.6 (2.1 to 5.1) |
| Women (n=1292) | 85.1 (82.8 to 87.4) | 8.7 (6.9 to 10.5) | 2.5 (1.5 to 3.5) | 0.4 (0.0 to 0.8) | 3.3 (2.1 to 4.5) |
| Age group | |||||
| 65–69 years (n=472) | 94.0 (91.5 to 96.5) | 5.1 (2.7 to 7.5) | 0.1 (0.0 to 0.5) | 0.1 (0.0 to 0.7) | 0.7 (0.0 to 1.6) |
| 70–74 years (n=506) | 88.6 (85.3 to 91.9) | 7.1 (4.5 to 9.8) | 2.4 (0.9 to 4.0) | 0.1 (0.0 to 0.4) | 1.8 (0.4 to 3.2) |
| 75–79 years (n=605) | 86.7 (83.5 to 89.9) | 7.9 (5.4 to 10.4) | 2.6 (1.1 to 4.1) | 0.4 (0.0 to 1.0) | 2.4 (0.9 to 3.8) |
| 80 years and older (n=549) | 76.0 (71.8 to 80.2) | 11.7 (8.5 to 14.9) | 3.1 (1.4 to 4.8) | 0.7 (0.0 to 1.5) | 8.5 (5.7 to 11.3) |
| 65–74 years (n=978) | 91.2 (89.1 to 93.3) | 6.1 (4.4 to 8.0) | 1.3 (0.5 to 2.1) | 0.1 (0.0 to 0.3) | 1.3 (0.5 to 2.2) |
| 75 years and older (n=1154) | 80.9 (78.2 to 83.6) | 9.9 (7.9 to 11.9) | 2.9 (1.7 to 4.1) | 0.6 (0.1 to 1.1) | 5.7 (4.1 to 7.3) |
Grade 0, absence of any signs of grades 1–3.
Grade 1, soft distinct drusen (≥63 μm) only or pigmentary abnormalities only (no soft drusen).
Grade 2, soft indistinct drusen (≥125 μm) or reticular drusen only or soft indistinct drusen (≥63 μm) with pigmentary abnormalities.
Grade 3, soft indistinct drusen (≥125 μm) or reticular drusen only with pigmentary abnormalities.
Grade 4, atrophic or neovascular AMD. In 65 cases, it was not possible to classify the image obtained for at least one eye.
↵* Data are shown as percentages and 95% CIs.